Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease

Plasma leucine-Rich α-2-glycoprotein 1 (LRG1) is an innovative biomarker for inflammation and angiogenesis. Many adverse pathophysiological changes including inflammation, atherosclerosis, and premature mortality is associated with End-stage renal disease (ESRD). However, whether levels of plasma LR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific reports 2020-04, Vol.10 (1), p.5988-5988, Article 5988
Hauptverfasser:	Yang, Feng-Jung, Hsieh, Chun-Yih, Shu, Kai-Hsiang, Chen, I-Yu, Pan, Szu-Yu, Chuang, Yi-Fang, Chiu, Yen-Ling, Yang, Wei-Shiung
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4022/1950/1544 692/53/2423 Aged Angiogenesis Arteriosclerosis Atherosclerosis Biomarkers - blood C-reactive protein C-Reactive Protein - metabolism Calcium phosphates Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - blood Cardiovascular Diseases - etiology Cell differentiation Cerebral infarction Coronary artery Demography Diabetes mellitus Disease Progression End-stage renal disease Female Flow cytometry Glycoproteins Glycoproteins - blood Health risk assessment Heart diseases Hemodialysis Hemoglobin Humanities and Social Sciences Humans Inflammation Interleukin 6 Kidney diseases Kidney Failure, Chronic - blood Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Leucine Lymphocytes T Male Middle Aged Monocytes Morbidity Mortality multidisciplinary Myocardial infarction Prognosis Regression analysis Renal Dialysis Science Science (multidisciplinary)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!